How Alnylam Assist™ Can Help Your Patients
Alnylam Assist™ is committed to helping patients access therapy. Your patient will work with an Alnylam Case Manager to help them have a smooth treatment experience with AMVUTTRA® (vutrisiran) and answer questions they may have along the way.
Alnylam Assist™ Support Overview
Your patient's Start Form has been submitted. Upon receipt of the Start Form, an Alnylam Case Manager will reach out to you and your patient within 2 business days. Your patient's Case Manager can help them with the following:
Help determine patient-specific coverage requirements, which include the following:
•Initiate a benefit verification for your patient and provide you and your patient with a benefit verification summary
•Provide information about patient financial assistance programs for eligible patients,a if necessary
Education on the prior authorizations, claims, and appeals processes
Explain the requirements and processes for prior authorizations, claims, and appeals, which include the following:
•Research the payer requirements as part of the benefit verification process
•Discuss the standard process for submitting a prior authorization and reimbursement claims
•Investigate reasons for denied or rejected prior authorizations, claims, and/or appeals
Alnylam offers financial assistance programs for eligible patients. After being prescribed an Alnylam product, your patient can talk to an Alnylam Case Manager to learn more. Below are examples of two Alnylam financial assistance programs.a
•Patient Assistance Program (PAP): Provides Alnylam product at no cost to eligible patients, primarily the uninsured, who meet specified financial criteria
•Commercial Copay Program: Covers certain out-of-pocket costs for eligible patients with commercial insuranceb
a Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue any program at any time.
b Patients with Medicare, Medicaid, or other government sponsored insurance are not eligible for the Alnylam Assist™ Commercial Copay Program. Out-of-pocket costs for the administration of AMVUTTRA will not be covered for patients residing where it is prohibited by law or where otherwise restricted.
Disease and Treatment Education
Provide information to your patients:
•A Patient Starter Kit, including educational materials designed to help patients understand AMVUTTRA and Alnylam Assist™
•Education for your patients from a designated Alnylam Patient Education Liaison (PEL)* to help them gain a better understanding of hATTR amyloidosis and treatment.
* PELs are employees of Alnylam Pharmaceuticals and do not provide medical advice.
Ordering product for your patient
a Alnylam reserves the right to make eligibility determinations and to modify or discontinue any program at any time.
b Patients with Medicare, Medicaid, or other government sponsored insurance are not eligible for the Alnylam Assist™ commercial copay program. Out-of-pocket costs for the administration of AMVUTTRA will not be covered for patients residing where it is prohibited by law or where otherwise restricted.
Alnylam Field Reimbursement Directors
Alnylam Field Reimbursement Directors (FRDs) are available to provide education about coverage, coding and reimbursement process for AMVUTTRA. FRDs will share their knowledge of:
•AMVUTTRA billing and coding requirements
•Chart documentation requirements
Where can I find the necessary forms and documents to enroll patients in Alnylam Assist™?
Alnylam Assist™ provides all the required forms and documents to enroll your patients, as well as downloadable educational resources. View the associated AMVUTTRA forms and documents ›
Enrolling Your Patients
Together with your patient